EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS

被引：0
|
作者：
Roland Buhl
Michael Dreher
Muriel Mattiucci-Guehlke
Rachel Emerson-Stadler
Sebastian Eckhardt
Christian Taube
Claus F. Vogelmeier
机构：
[1] Mainz University Hospital,Pulmonary Department
[2] University Hospital RWTH Aachen,Department of Pneumology and Intensive Care Medicine
[3] HP Country Medical Affairs,Department of Pulmonary Medicine
[4] Boehringer Ingelheim Pharma GmbH & Co. KG,Department of Medicine, Pulmonary and Critical Care Medicine
[5] Boehringer Ingelheim International GmbH,undefined
[6] Alcedis GmbH,undefined
[7] University Hospital Essen,undefined
[8] Ruhrlandklinik,undefined
[9] University Duisburg-Essen,undefined
[10] University Medical Center Gießen and Marburg,undefined
[11] German Center for Lung Research (DZL),undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
COPD; EVELUT; LABA/ICS; LAMA/LABA; LAMA/LABA/ICS; Observational; Triple therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3263 / 3278
页数：15
相关论文
共 50 条
  • [41] Late Breaking Abstract - Impact of ICS/LABA and LABA/LAMA FDCs on lung function and exacerbation of COPD: a network meta-analysis
    Di Marco, Fabiano
    Calzetta, Luigino
    Rogliani, Paola
    Blasi, Francesco
    Centanni, Stefano
    Micheletto, Claudio
    Rossi, Andrea
    Cazzola, Mario
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [42] Assessment of efficacy and tolerability of roflumilast add-on to LABA/LAMA/ICS in the treatment of COPD in Indian patients
    Mandke, Kshitij
    Mandke, Anup
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [43] LABA/LAMA versus LABA/ICS fixed-dose combinations in the prevention of COPD exacerbations: a modeling analysis of literature aggregate data
    Yiwen Gong
    Zichao Sui
    Yinghua Lv
    Qingshan Zheng
    Lujin Li
    [J]. European Journal of Clinical Pharmacology, 2023, 79 : 1321 - 1332
  • [44] Heterogeneous treatment effect estimation of LABA/LAMA/ICS on COPD exacerbation risk in the IMPACT trial
    Verstraete, Kenneth
    Gyselinck, Iwein
    Huts, Helene
    De Vos, Maarten
    Janssens, Wim
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [45] Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?
    Tariq, Syed Mohammad
    Thomas, Enson C.
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 1877 - 1882
  • [46] 联合吸入LABA、ICS、LAMA对COPD患者肺功能的影响
    冼宏
    叶永青
    陈利霞
    甘凤英
    刘国栋
    [J]. 深圳中西医结合杂志, 2021, 31 (05) : 143 - 144
  • [47] Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD
    Calzetta, Luigino
    Cazzola, Mario
    Matera, Maria Gabriella
    Rogliani, Paola
    [J]. CHEST, 2019, 155 (04) : 758 - 770
  • [48] Which LABA/LAMA should be chosen in COPD patients in real life?
    Sposato, Bruno
    Petrucci, Elisa
    Serafini, Andrea
    Lena, Fabio
    Lacerenza, Leonardo Gianluca
    Montagnani, Andrea
    Alessandri, Massimo
    Cresti, Alberto
    Scala, Raffaele
    Rogliani, Paola
    Ricci, Alberto
    Perrella, Antonio
    Scalese, Marco
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2021, 71
  • [49] Comparison of LAMA/LABA vs ICS/LABA in high risk COPD patients: Pre-specified analysis on lung function and health status from the IMPACT trial
    Lipson, David A.
    Barnhart, Frank
    Boucot, Isabelle
    Crim, Courtney
    Brealey, Noushin
    Criner, Gerard J.
    Dransfield, Mark
    Halpin, David M. G.
    Kilbride, Sally
    Han, Meilan K.
    Lange, Peter
    Lomas, David A.
    Martinez, Fernando J.
    Singh, Dave
    Naya, Ian Naya
    Jones, Christine Elaine
    Wise, Robert
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [50] A Prospective Non-Interventional Study in COPD Patients That Evolve to Fixed LABA/LAMA/ICS Triple Therapy (TRIVOLVE)
    Brusselle, G. G.
    Himpe, U.
    Haerens, M.
    Fievez, P.
    Leduc, D.
    Peche, R.
    Vanderhelst, E.
    Rommes, B.
    Geelissen, S.
    Gesquiere, I.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345